Wintle M - Search Results

1

Addition of exenatide BID to insulin glargine: a post-hoc analysis of the effect on glycemia and weight across a range of insulin titration.

Buse JB, Han J, Miller S, MacConell L, Pencek R, Wintle M. Buse JB, et al. Among authors: wintle m. Curr Med Res Opin. 2014 Jul;30(7):1209-18. doi: 10.1185/03007995.2014.896329. Epub 2014 Mar 18. Curr Med Res Opin. 2014. PMID: 24621255 Clinical Trial.

2

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials.

Buse JB, Klonoff DC, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Maggs DG, Wintle ME. Buse JB, et al. Clin Ther. 2007 Jan;29(1):139-53. doi: 10.1016/j.clinthera.2007.01.015. Clin Ther. 2007. PMID: 17379054 Clinical Trial.

3

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years.

Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG. Klonoff DC, et al. Among authors: wintle me. Curr Med Res Opin. 2008 Jan;24(1):275-86. doi: 10.1185/030079908x253870. Curr Med Res Opin. 2008. PMID: 18053320 Clinical Trial.

4

Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.

Gaebler JA, Soto-Campos G, Alperin P, Cohen M, Blickensderfer A, Wintle M, Maggs D, Hoogwerf B, Han J, Pencek R, Peskin B. Gaebler JA, et al. Among authors: wintle m. Vasc Health Risk Manag. 2012;8:255-64. doi: 10.2147/VHRM.S28744. Epub 2012 Apr 23. Vasc Health Risk Manag. 2012. PMID: 22566747 Free PMC article.

5

A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic exendin-4).

Calara F, Taylor K, Han J, Zabala E, Carr EM, Wintle M, Fineman M. Calara F, et al. Among authors: wintle m. Clin Ther. 2005 Feb;27(2):210-5. doi: 10.1016/j.clinthera.2005.02.008. Clin Ther. 2005. PMID: 15811484 Clinical Trial.

6

Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials.

DeFronzo RA, Stonehouse AH, Han J, Wintle ME. DeFronzo RA, et al. Among authors: wintle me. Diabet Med. 2010 Mar;27(3):309-17. doi: 10.1111/j.1464-5491.2010.02941.x. Diabet Med. 2010. PMID: 20536494 Review.

7

Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine.

Fabunmi R, Nielsen LL, Quimbo R, Schroeder B, Misurski D, Wintle M, Wade R. Fabunmi R, et al. Among authors: wintle m. Curr Med Res Opin. 2009 Mar;25(3):777-86. doi: 10.1185/03007990802715199. Curr Med Res Opin. 2009. PMID: 19203299

8

Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world setting.

Bergenstal RM, Garrison LP Jr, Wintle M, Blickensderfer A, Wade R, Hou L, Miller LA, Scism-Bacon J, Zagar A, Misurski D, Herman WH. Bergenstal RM, et al. Among authors: wintle m. Curr Med Res Opin. 2011 Mar;27(3):531-40. doi: 10.1185/03007995.2010.545814. Epub 2011 Jan 10. Curr Med Res Opin. 2011. PMID: 21219119

9

Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A. Yu AP, et al. Among authors: wintle m. Curr Med Res Opin. 2007 Sep;23(9):2157-69. doi: 10.1185/0300799007X219544. Curr Med Res Opin. 2007. PMID: 17669232 Review.

10

The incretin mimetic exenatide as a monotherapy in patients with type 2 diabetes.

Nelson P, Poon T, Guan X, Schnabel C, Wintle M, Fineman M. Nelson P, et al. Among authors: wintle m. Diabetes Technol Ther. 2007 Aug;9(4):317-26. doi: 10.1089/dia.2006.0024. Diabetes Technol Ther. 2007. PMID: 17705687 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page